An Insulin Replacement?
A new once-a-week drug may be as good as insulin in controlling diabetes, according to research.
A study conducted by the drug’s manufacturer, GlaxoSmithKline, showed that albiglutide reduced blood-sugar levels as much as insulin over a period of 26 weeks.
Blood-sugar levels dropped 0.82 percent for patients on the drug, while research subjects taking insulin saw a drop of 0.82 percent. Patients in the study also lost an average of 1.6 pounds, while the patients on insulin gained 1.8 pounds.
A similar drug, Bydureon, is now on the market after a 12-year approval process with the federal Food and Drug Administration.
GlaxoSmithKline said that albiglutide may be on the market by 2013.